Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Marker Expression in Pediatric Patients With Immune Thrombocytopenic Purpura Receiving Second Line Therapy

NCT06093529 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06093529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06093529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Marker Expression in Pediatric Patients With Immune Thrombocytopenic Purpura Receiving Second Line Therapy
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2024
Completion date
February 1, 2025
Enrollment
42 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

itp - immune thrombocytopenia